136 related articles for article (PubMed ID: 11158145)
1. Comparative evaluation of semiautomated COBAS AMPLICOR hepatitis B virus (HBV) monitor test and manual microwell plate-based AMPLICOR HBV MONITOR test.
Marin IJ; Poljak M; Seme K; Meglic-Volkar J; Maticic M; Lesnicar G; Brinovec V
J Clin Microbiol; 2001 Feb; 39(2):758-61. PubMed ID: 11158145
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the COBAS TaqMan HBV test with the COBAS Amplicor monitor test for measurement of hepatitis B virus DNA in serum.
Sum SS; Wong DK; Yuen JC; Lai CL; Yuen MF
J Med Virol; 2005 Dec; 77(4):486-90. PubMed ID: 16254975
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of the digene hybrid capture II test and the COBAS AMPLICOR monitor test for determination of hepatitis B virus DNA levels.
Yuan HJ; Yuen MF; Wong DK; Sum SS; Lai CL
J Clin Microbiol; 2004 Aug; 42(8):3513-7. PubMed ID: 15297491
[TBL] [Abstract][Full Text] [Related]
4. Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.
Hochberger S; Althof D; Gallegos de Schrott R; Nachbaur N; Röck H; Leying H
J Clin Virol; 2006 Apr; 35(4):373-80. PubMed ID: 16461000
[TBL] [Abstract][Full Text] [Related]
5. Detection and quantitation of HBV DNA in miniaturized samples: multi centre study to evaluate the performance of the COBAS ® AmpliPrep/COBAS ® TaqMan ® hepatitis B virus (HBV) test v2.0 by the use of plasma or serum specimens.
Berger A; Gohl P; Stürmer M; Rabenau HF; Nauck M; Doerr HW
J Virol Methods; 2010 Nov; 169(2):404-8. PubMed ID: 20728470
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the COBAS amplicor HBV monitor assay and comparison with the ultrasensitive HBV hybrid capture 2 assay for quantification of hepatitis B virus DNA.
Konnick EQ; Erali M; Ashwood ER; Hillyard DR
J Clin Microbiol; 2005 Feb; 43(2):596-603. PubMed ID: 15695651
[TBL] [Abstract][Full Text] [Related]
7. Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard.
Weiss J; Wu H; Farrenkopf B; Schultz T; Song G; Shah S; Siegel J
J Clin Virol; 2004 May; 30(1):86-93. PubMed ID: 15072760
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of three commercial assays for quantitative measurement of hepatitis B virus DNA in serum samples.
Marin IJ; Poljak M; Seme K; Brinovec V; Maticic M; Meglic-Volkar J; Lesnicar G; Gradisek P
Hepatogastroenterology; 2002; 49(47):1390-4. PubMed ID: 12239949
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay.
Ronsin C; Pillet A; Bali C; Denoyel GA
J Clin Microbiol; 2006 Apr; 44(4):1390-9. PubMed ID: 16597867
[TBL] [Abstract][Full Text] [Related]
10. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM
J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
[TBL] [Abstract][Full Text] [Related]
11. Second-generation Hybrid capture test and Amplicor monitor test generate highly correlated hepatitis B virus DNA levels.
Poljak M; Marin IJ; Seme K; Brinovec V; Maticic M; Meglic-Volkar J; Lesnicar G; Vince A
J Virol Methods; 2001 Sep; 97(1-2):165-9. PubMed ID: 11483227
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of hepatitis B virus DNA by real-time PCR using internal amplification control and dual TaqMan MGB probes.
Lole KS; Arankalle VA
J Virol Methods; 2006 Jul; 135(1):83-90. PubMed ID: 16551481
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Versant HBV DNA 3.0 and COBAS AmpliPrep-COBAS TaqMan assays for hepatitis B DNA quantitation: Possible clinical implications.
Garbuglia AR; Angeletti C; Lauria FN; Zaccaro P; Cocca AM; Pisciotta M; Solmone M; Capobianchi MR
J Virol Methods; 2007 Dec; 146(1-2):274-80. PubMed ID: 17707918
[TBL] [Abstract][Full Text] [Related]
15. Real-time PCR assay using molecular beacon for quantitation of hepatitis B virus DNA.
Sum SS; Wong DK; Yuen MF; Yuan HJ; Yu J; Lai CL; Ho D; Zhang L
J Clin Microbiol; 2004 Aug; 42(8):3438-40. PubMed ID: 15297480
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
[TBL] [Abstract][Full Text] [Related]
18. Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients.
Mazet-Wagner AA; Baclet MC; Loustaud-Ratti V; Denis F; Alain S
J Virol Methods; 2006 Dec; 138(1-2):70-9. PubMed ID: 16962180
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study.
Jarvis L; Becker J; Tender A; Cleland A; Queiros L; Aquiar A; Azevedo J; Aprili G; Bressan F; Torres P; Nieto S; Ursitti A; Montoro J; Vila E; Ramada C; Saldanha J
Transfusion; 2008 Sep; 48(9):1853-61. PubMed ID: 18513254
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.
Konnick EQ; Williams SM; Ashwood ER; Hillyard DR
J Clin Microbiol; 2005 May; 43(5):2133-40. PubMed ID: 15872232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
